系统性炎症和心房相关性中风后的复发:一个个体参与者的数据元分析
John J McCabe1,2,3, Katie Harris4, Sarah Gorey1,2,3
1Health Research Board (HRB) Stroke Clinical Trials Network Ireland (SCTNI), Ireland.
Neurology
|February 16, 2026
概括
像hsCRP这样的炎症标志物与中风后的复发性心血管事件有关,无论心房 (AF) 病史如何. 这支持将AF患者纳入基于炎症水平升高的抗炎试验.
科学领域:
- 心血管医学 心血管医学
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 尽管服用抗凝血药物,心房动 (AF) 的中风复发风险很高,需要新的治疗方法.
- 炎症在AF中起着关键作用,但AF患者被排除在抗炎试验之外.
- 与AF状态相关的IL-6/hsCRP和中风后复发之间的关联尚不清楚.
研究的目的:
- 根据AF状态分层分析IL-6/hsCRP和中风/MACE复发之间的关联.
- 为了确定AF是否修改了炎症标志物和血管复发之间的联系.
- 为未来的抗炎疗法试验设计提供信息.
主要方法:
- 分析了来自11项前性研究的个人参与者数据.
- 多变量考克斯回归模型评估了IL-6/hsCRP和复发性中风/MACE之间的关联.
- 分析根据AF状态进行了分层,并根据混因素进行了调整.
主要成果:
- 在AF患者中观察到较高的炎症标志物 (IL-6,hsCRP).
- 不管AF状态如何,hsCRP与复发的MACE相关 (P相互作用=0.30).
- 在hsCRP和复发性中风之间没有发现显著的关联;IL-6在MACE或中风复发方面没有显示AF相互作用.
结论:
- 炎症机制对于血管复发至关重要,独立于AF.
- 这些发现支持将AF患者纳入抗炎疗法试验.
- 未来的试验应该考虑根据炎症标记升高的患者选择,而不仅仅是中风病因.
相关概念视频
01:26Atherosclerosis III: Management
460
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
468
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
468
01:18Endocarditis III: Medical Management
269
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
269
01:30Acute Coronary Syndrome III: Diagnostic Studies
298
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
01:21Rheumatic Heart Disease III: Medical Management
393
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
393
01:30Acute Coronary Syndrome I: Introduction
1.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K